Bharat Biotech arm, VeGen Bio plan advanced cancer treatment manufacturing
In short
Bharat Biotech’s arm and VeGen Bio plan to make an advanced cancer treatment. The report says they are aiming to commercialise a blood cancer therapy by 2028.
This matters because it shows Bharat Biotech moving further into cell and gene therapies. The reporting does not say where the treatment will be made or what approvals are still needed.
What the reporting says
Bharat Biotech’s arm and VeGen Bio plan to manufacture an advanced cancer treatment, with commercialisation of a blood cancer therapy targeted by 2028. The report says the partnership expands Bharat Biotech’s push into cell and gene therapies. No further terms, development stage, or regulatory timeline are stated in the available reporting.
Why it matters
Bharat Biotech’s arm and VeGen Bio plan to manufacture an advanced cancer treatment, with commercialisation of a blood cancer therapy targeted by 2028. The available reporting says the deal expands Bharat Biotech’s push into cell and gene therapies. It does not state the production site, deal value, or regulatory steps, so the near-term commercial path remains unclear.